Developers: | I. Kant Baltic Federal University (I. Kant BFU) |
Date of the premiere of the system: | August 2023 |
Branches: | Pharmaceuticals, Medicine, Healthcare |
2023: Product Announcement
In Russia, presented a device for painless sampling of biomaterial in cervical diseases. We are talking about the development of the Baltic Federal University. I. Kant (BFU), the press service of the Platform for University Technological Entrepreneurship at the end of August 2023.
The medical kit created by BFU specialists for non-invasive, that is, non-traumatic collection of biomaterial, uses a technology that has not previously been used in diagnostic procedures on the cervix. The principle of operation of the cell-block technology proposed by the developers is as follows: the biomaterial is placed in a colloidal solution (a jelly-like mass in which a solid is distributed in a liquid), cooled, and the resulting clot containing cells and tissue fragments is degreased and dehydrated. The remainder is studied under a microscope or other research methods. Moreover, the biomaterial for diagnosis is collected without damage to the surface of the cervix.
We changed the existing method somewhat and made it cheaper at the expense of the components. The technique is simple, safe and cost effective... The advantages are also a wide range of use of the kit (not only in gynecology), an increase in the storage time of the material, as well as the ability to conduct a multidisciplinary study (cytologists and pathologists), - explained the project manager Anastasia Antishina, whose words are quoted by TASS. |
By the end of August 2023, developers are studying the need for a device in the laboratory diagnostics market. In the Kaliningrad region, the novelty interested healthcare specialists. The number of consumers of laboratory diagnostics services in Russia over the past three years has grown by 12%, TASS indicates on August 28, 2023.[1]